Medium-to-high prevalence of screening-detected parkinsonism in the urban area of Tehran, Iran: data from a community-based door-to-door study

Abstract

IntroductionParkinsonism occurs in all ethnic groups worldwide; however, there are wide variations in the prevalence rates reported from different countries, even for neighboring regions. The huge socioeconomic burden of parkinsonism necessitates the need for prevalence studies in each country. So far, there is neither data registry nor prevalence information on parkinsonism in the Iranian population. The aim of our study was to estimate the prevalence rate of probable parkinsonism in a huge urban area in Iran, Tehran using a community-based door-to-door survey.Materials and methodsWe used a random multistage sampling of the households within the network of health centers consisting of 374 subunits in all 22 districts throughout the entire urban area of Tehran. Overall, 20,621 individuals answered the baseline checklist and screening questionnaire and data from 19,500 persons aged ≥30 years were entered in the final analysis. Health care professionals used a new six-item screening questionnaire for parkinsonism, which has been previously shown to have a high validity and diagnostic value in the same population.ResultsA total of 157 cases were screened for parkinsonism using the validated six-item questionnaire. After age and sex adjustment based on the Tehran population, the prevalence of parkinsonism was calculated as 222.9 per 100,000. Using the World Health Organization’s World Standard Population, the standardized prevalence rate of parkinsonism was 285 per 100,000 (95% confidence interval 240–329). The male:female ratio of probable parkinsonism was calculated as 1.62, and there was a significant increase in the screening rate by advancing age.ConclusionThe calculated rates for the prevalence of parkinsonism in our study are closer to reports from some European and Middle Eastern countries, higher than reports from Eastern Asian and African populations, and lower than Australia. The prevalence rate of >200 in 100,000 for parkinsonism in Tehran, Iran could be considered a medium-to-high rate.

Prevalence and associated comorbidities of restless legs syndrome (RLS): Data from a large population-based door-to-door survey on 19176 adults in Tehran, Iran

“…This Population-based door-to-door survey was performed in the metropolitan area of Tehran, Iran consisting of 22 urban districts during October 2011 and January 2012. Present study is a part of a larger project designed to study the epidemiologic features of the major neurological disorders, which has been previously described [ 11 ].…”

Stereological Evaluation of the Brains in Patients with Parkinson’s disease Compared to Controls

“…In US it is about 150 per 100,000 in all ages and reaches to approximately 800 per 100,000 at 70 to 85 (7). Epidemiological studies in Iran showed that its prevalence is medium -to-high and estimated to be more than 200 per 100,000 people (8). It is actually more frequent in men than women and progresses faster in male than female patients (5).…”

Safety Predictors in Performance of Activities of Daily Living in Patients with Parkinson’s Disease

“…The prevalence of PD was estimated at 222.9 per 100,000 people, with a male-to-female ratio of 1:62 in Tehran, Iran (2). Besides motor symptoms, such as bradykinesia, rigidity, and tremor, nonmotor symptoms, including fatigue, mood disorders, pain, and cognitive impairment, are major factors leading to disability (3).…”